BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33129220)

  • 21. Should endometrial biopsy under direct hysteroscopic visualization using the grasp technique become the new gold standard for the preoperative evaluation of the patient with endometrial cancer?
    Di Spiezio Sardo A; De Angelis MC; Della Corte L; Carugno J; Zizolfi B; Guadagno E; Gencarelli A; Cecchi E; Simoncini T; Bifulco G; Zullo F; Insabato L
    Gynecol Oncol; 2020 Aug; 158(2):347-353. PubMed ID: 32467056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer.
    Sawicki W; Spiewankiewicz B; Stelmachów J; Cendrowski K
    Eur J Gynaecol Oncol; 2003; 24(3-4):293-8. PubMed ID: 12807243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?
    Yan B; Zhao T; Liang X; Niu C; Ding C
    Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative and postoperative correlation of histopathological findings in cases of endometrial hyperplasia.
    Gundem G; Sendag F; Kazandi M; Akercan F; Mgoyi L; Terek MC; Zekioglu O
    Eur J Gynaecol Oncol; 2003; 24(3-4):330-3. PubMed ID: 12807251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
    Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
    Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP).
    Jegatheeswaran K; Cormier B; Dube S; Gotlieb WH; Helpman L; Kwon JS; Lau S; Mah S; May T; Saab D; McNeill M; Plante M; Renaud MC; Shamiya S; Vicus D; Parra-Herran C; Feigenberg T
    Gynecol Oncol; 2020 Oct; 159(1):52-57. PubMed ID: 32694064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
    Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
    Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Concordance between preoperative and definitive study in endometrial cancer].
    Mazón-González B; Olguín-Cruces VA
    Rev Med Inst Mex Seguro Soc; 2017; 55 Suppl 1():S26-S33. PubMed ID: 28212472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of tumor grade by preoperative curettage and associated clinicopathologic factors in clinical stage I endometriod adenocarcinoma.
    Wang XY; Pan ZM; Chen XD; Lü WG; Xie X
    Chin Med J (Engl); 2009 Aug; 122(16):1843-6. PubMed ID: 19781357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.
    Lefringhouse JR; Elder JW; Baldwin LA; Miller RW; DeSimone CP; van Nagell JR; Samoyoa LM; West DS; Dressler EV; Liu M; Ueland FR
    Gynecol Oncol; 2017 Apr; 145(1):50-54. PubMed ID: 28190648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable outcome between endometrioid and non-endometrioid tumors in patients with early-stage high-grade endometrial cancer.
    Reynaers EA; Ezendam NP; Pijnenborg JM
    J Surg Oncol; 2015 May; 111(6):790-4. PubMed ID: 25900897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.
    Yen TT; Miyamoto T; Asaka S; Chui MH; Wang Y; Lin SF; Stone RL; Fader AN; Asaka R; Kashima H; Shiozawa T; Wang TL; Shih IM; Tanner EJ
    Gynecol Oncol; 2018 Sep; 150(3):426-431. PubMed ID: 30126589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure to recognize preoperatively high-risk endometrial carcinoma is associated with a poor outcome.
    Di Cello A; Rania E; Zuccalà V; Venturella R; Mocciaro R; Zullo F; Morelli M
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():153-60. PubMed ID: 26409060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
    Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
    Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.